Latest research report on “Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Research Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5552179
A biomarker is, according to the US National Institutes of Health, a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention.
Biomarkers make take the form of cellular characteristics, metabolites (e.g. sugars, lipids and hormones), molecular variations, or physical features (e.g., clinical symptoms) and are assessed accordingly, via measurement, annotation, documents, and images.
Increasingly, the discovery of novel biomarkers is closely associated with the advances in molecular biology techniques that can be accessed through analysis of DNA, RNA or proteins.
We can discriminate four main types of molecular biomarkers:
Genomic biomarkers: Based on the analysis of DNA (deoxyribonucleic acid) profiles, especially the analysis of SNPs (single nucleotide polymorphisms), i.e. identification of punctual variations in genomic DNA.
Transcriptomic biomarkers: Base on the analysis of RNA expression profiles.
Proteomic biomarkers: Base on the analysis of the protein profiles.
Metabolomic biomarkers: Base on the analysis of metabolites (metabolites are the intermediates and products of metabolism).
Commercializing biomarkers is the path that a biomarker could be used in therapeutic or diagnostic. In this report mainly covers consumables, services, software of this market.
This report contains market size and forecasts of Commercializing Biomarkers in Therapeutic and Diagnostic Applications in Global, including the following market information:
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market was valued at 22010 million in 2021 and is projected to reach US$ 30140 million by 2028, at a CAGR of 4.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Consumables Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Commercializing Biomarkers in Therapeutic and Diagnostic Applications include Roche, Dako (Agilent Technologies), Merck, BD, Abbott, Genesys Biolabs (20/20GeneSystems), Affymetrix, Agendia and ALMAC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Commercializing Biomarkers in Therapeutic and Diagnostic Applications companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Segment Percentages, by Type, 2021 (%)
– Consumables
– Services
– Software
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Segment Percentages, by Application, 2021 (%)
– Oncology
– Cardiology
– Neurology
– Other
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– Europe
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– Asia
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Commercializing Biomarkers in Therapeutic and Diagnostic Applications revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Commercializing Biomarkers in Therapeutic and Diagnostic Applications revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– Roche
– Dako (Agilent Technologies)
– Merck
– BD
– Abbott
– Genesys Biolabs (20/20GeneSystems)
– Affymetrix
– Agendia
– ALMAC
– Arrayit
– Biocartic
– BG Medicine
– KEGG EXPRESSION Database
– Thermo Fisher
– BGI
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5552179
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441